Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111757943 | 11175794 | 3 | F | 201408 | 20160816 | 20150609 | 20160818 | EXP | US-PFIZER INC-2015188807 | PFIZER | 52.00 | YR | F | Y | 77.00000 | KG | 20160818 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111757943 | 11175794 | 1 | PS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 100 MG, 1X/DAY | 21992 | 100 | MG | PROLONGED-RELEASE TABLET | QD | ||||||
| 111757943 | 11175794 | 2 | C | DILANTIN | PHENYTOIN | 1 | UNK | 0 | |||||||||||
| 111757943 | 11175794 | 3 | C | TEMAZEPAM. | TEMAZEPAM | 1 | UNK | 0 | |||||||||||
| 111757943 | 11175794 | 4 | C | TRAMADOL. | TRAMADOL | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111757943 | 11175794 | 1 | Crying |
| 111757943 | 11175794 | 2 | Seizure |
| 111757943 | 11175794 | 3 | Sleep disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111757943 | 11175794 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111757943 | 11175794 | Anxiety | |
| 111757943 | 11175794 | Brain injury | |
| 111757943 | 11175794 | Coma | |
| 111757943 | 11175794 | Fall | |
| 111757943 | 11175794 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |